Department of Thoracic Surgery, Medical University of Gdansk, Gdansk, Poland.
Data Mining Group, Institute of Automatic Control, Silesian University of Technology, Gliwice, Poland.
Eur J Cardiothorac Surg. 2018 Sep 1;54(3):547-553. doi: 10.1093/ejcts/ezy101.
The video-assisted thoracoscopic surgery (VATS) approach has become a standard for the treatment of early-stage non-small-cell lung cancer (NSCLC). Recently published meta-analyses proved the benefit of VATS versus thoracotomy for overall survival (OS) and reduction of postoperative complications. The aim of this study was to compare early outcomes, long-term survival and rate of postoperative complications of the VATS approach versus thoracotomy.
In this retrospective cohort study, we analysed 982 individuals who underwent surgical resection for Stage I-IIA NSCLC between 2007 and 2015. Thirty- and 90-day mortality rates, length of hospital stay, rate of complications and OS were assessed. Propensity score matching was performed to compare 2 groups of patients. Two hundred and twenty-five individuals from the thoracotomy group and 225 patients from the VATS group were matched regarding pTNM, sex, the Charlson comorbidity index, type of resection and histological diagnosis.
In the propensity score-matched patient group, the VATS approach was associated with a significant benefit regarding OS (P = 0.042). Although no significant difference was observed (P = 0.14) in the 3-year survival rate of patients who had a thoracotomy versus VATS, the 5-year survival rate among patients with VATS increased significantly (61% vs 78%, P = 0.0081). The adjusted VATS-related hazard ratio for pTNM, sex and age was 0.63 (95% confidence interval 0.40-0.98). The VATS surgical approach also reduced both the rate of postoperative atelectasis (4% for VATS vs 10% for open thoracotomy; P = 0.0052) and the need for blood transfusions (4% vs 12% respectively, P = 0.0054) and significantly shortened the postoperative length of stay (mean 7.25 vs 9.34 days, P < 0.0001). No significant differences in the 30-day mortality (1% vs 1%, P = 0.66) and 90-day mortality (1% vs 1%, P = 0.48) rates were observed.
Patients with early-stage NSCLC operated on with VATS had fewer complications, shorter postoperative length of stay and better OS compared to those who were operated on by thoracotomy.
电视辅助胸腔镜手术(VATS)已成为治疗早期非小细胞肺癌(NSCLC)的标准方法。最近发表的荟萃分析证明,VATS 与开胸手术相比,在总生存(OS)和减少术后并发症方面具有优势。本研究旨在比较 VATS 与开胸手术的早期结果、长期生存和术后并发症发生率。
本回顾性队列研究分析了 2007 年至 2015 年间接受 I 期-IIA 期 NSCLC 手术切除的 982 名患者。评估了 30 天和 90 天死亡率、住院时间、并发症发生率和 OS。采用倾向评分匹配比较两组患者。对开胸组的 225 名患者和 VATS 组的 225 名患者进行了基于 pTNM、性别、Charlson 合并症指数、切除类型和组织学诊断的倾向评分匹配。
在倾向评分匹配的患者组中,VATS 方法与 OS 显著相关(P=0.042)。尽管接受开胸手术和 VATS 的患者 3 年生存率无显著差异(P=0.14),但 VATS 组的 5 年生存率显著升高(61%比 78%,P=0.0081)。VATS 相关的 pTNM、性别和年龄的调整风险比为 0.63(95%置信区间 0.40-0.98)。VATS 手术还降低了术后肺不张的发生率(VATS 为 4%,开胸手术为 10%;P=0.0052)和输血需求(VATS 为 4%,开胸手术为 12%;P=0.0054),并显著缩短了术后住院时间(平均 7.25 天比 9.34 天,P<0.0001)。30 天死亡率(1%比 1%,P=0.66)和 90 天死亡率(1%比 1%,P=0.48)无显著差异。
与开胸手术相比,接受 VATS 治疗的早期 NSCLC 患者并发症更少,术后住院时间更短,OS 更好。